Callan Family Office’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.46M Buy
104,756
+4,888
+5% +$219K 0.09% 221
2026
Q1
$4.04M Buy
99,868
+83,453
+508% +$3.7M 0.09% 224
2025
Q4
$753K Buy
16,415
+7,901
+93% +$360K 0.02% 634
2025
Q3
$389K Sell
8,514
-17,579
-67% -$779K 0.01% 620
2025
Q2
$1.08M Buy
26,093
+14,466
+124% +$536K 0.03% 381
2025
Q1
$406K Sell
11,627
-8,005
-41% -$303K 0.03% 371
2024
Q4
$752K Buy
19,632
+3,417
+21% +$129K 0.05% 295
2024
Q3
$575K Buy
16,215
+106
+0.7% +$3.35K 0.1% 98
2024
Q2
$446K Buy
+16,109
New +$449K 0.09% 94

Other funds holding BN

Callan Family Office's BN Position: Q2 2026 in Review

Callan Family Office increased its Brookfield (BN) stake by 4.9% in Q2 2026, buying an estimated $219K and bringing the position to 104,756 shares worth $4.46M. The position accounts for 0.09% of the portfolio, ranked #221.

Callan Family Office first reported a position in BN in Q2 2024 and has held it in 9 quarters since. 944 funds tracked by Wall St. Rank hold BN as of Q2 2026.

  • Callan Family Office held 104,756 shares of Brookfield worth $4.46M as of Q2 2026.
  • Callan Family Office bought 4,888 Brookfield shares in Q2 2026, an estimated $219K.
  • Brookfield made up 0.09% of Callan Family Office's portfolio in Q2 2026, its #221 holding.
  • Callan Family Office first reported a position in Brookfield in Q2 2024 and has held it in 9 quarters since.
  • 944 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.